(Total Views: 537)
Posted On: 02/13/2018 3:05:26 PM
Post# of 74550
$AURX UNKNOWN TINY BLOODIED SECRET PHRMA. If you heard of it, you heard of AURX from me UNKNOWN. IHUB doesn't even have a message board for it (But they are always slower than I am so its not a big deal). TRADES ON THE HIGHEST TIER FOR AN OTC STOCK OTCQX was just trading at $2.00. "psst wanna know the jaw dropping share structure?" 02/12/2018
Authorized Shares
31,500,000
02/01/2018
Outstanding Shares
22,722,400
GOINGGGGG SHHHH.
"The big seller dumped 300,000 shares and collapsed the stock. Now it is a strong buy. Market cap is only $2MM and they have an FDA approved wound product. They just raised $3MM from private equity investors. The upside is huge when they get FDA approval through the CED program. FDA reimbursement gives them a 50% GPM. They have enough cash to get through early 2018. It is risky but the risk/reward is very favorable. The stock should be $.30 where the private placement closed last month. This is a unique opportunity to buy at a better price than the private placement which is locked up. Giddyup".
" Lots of upside from their wound care product and compassionate use granted by FDA while approval is in the works for expanded use. Tiny market cap gives it leveraged upside."
" I think it will get back up to $.30/shr and any good news about CMS reimbursement will take to $1 or higher."
Major Holders Currency in USD
Breakdown
72.64% % of Shares Held by All Insider
Direct Holders (Forms 3 and 4)
Name Shares Date Reported
SHEEDY CHARLES E 8,286,312 Aug 9, 2017
BOYALIFE INVESTMENT FUND I, INC. 4,900,000 Sep 10, 2017
PITTMAN SCOTT M. 2,935,800 Aug 9, 2017
JORDEN DAVID EMERSON 557,146 Aug 9, 2017
Authorized Shares
31,500,000
02/01/2018
Outstanding Shares
22,722,400
GOINGGGGG SHHHH.
"The big seller dumped 300,000 shares and collapsed the stock. Now it is a strong buy. Market cap is only $2MM and they have an FDA approved wound product. They just raised $3MM from private equity investors. The upside is huge when they get FDA approval through the CED program. FDA reimbursement gives them a 50% GPM. They have enough cash to get through early 2018. It is risky but the risk/reward is very favorable. The stock should be $.30 where the private placement closed last month. This is a unique opportunity to buy at a better price than the private placement which is locked up. Giddyup".
" Lots of upside from their wound care product and compassionate use granted by FDA while approval is in the works for expanded use. Tiny market cap gives it leveraged upside."
" I think it will get back up to $.30/shr and any good news about CMS reimbursement will take to $1 or higher."
Major Holders Currency in USD
Breakdown
72.64% % of Shares Held by All Insider
Direct Holders (Forms 3 and 4)
Name Shares Date Reported
SHEEDY CHARLES E 8,286,312 Aug 9, 2017
BOYALIFE INVESTMENT FUND I, INC. 4,900,000 Sep 10, 2017
PITTMAN SCOTT M. 2,935,800 Aug 9, 2017
JORDEN DAVID EMERSON 557,146 Aug 9, 2017
(0)
(0)
